These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11305528)

  • 1. Determination of the habitual low blood level of C-reactive protein in individuals.
    Kluft C; de Maat MP
    Ital Heart J; 2001 Mar; 2(3):172-80. PubMed ID: 11305528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects.
    Wood WG; Lüdemann J; Mitusch R; Heinrich J; Maass R; Frick U
    Clin Lab; 2000; 46(3-4):131-40. PubMed ID: 10791120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical-economical aspects of high sensitivity C-reactive protein assay for the prediction of coronary heart disease. An analysis in Germany and Italy.
    Ess SM; Szucs TD
    Ital Heart J; 2001 Mar; 2(3):181-8. PubMed ID: 11305529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
    Mora S; Rifai N; Buring JE; Ridker PM
    Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime earnings patterns, the distribution of future Social Security benefits, and the impact of pension reform.
    Bosworth B; Burtless G; Steuerle E
    Soc Secur Bull; 2000; 63(4):74-98. PubMed ID: 11641991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA; Glynn RJ; Ridker PM
    Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population.
    García-Lorda P; Bulló M; Balanzà R; Salas-Salvadó J
    Int J Obes (Lond); 2006 Mar; 30(3):468-74. PubMed ID: 16314875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic variability of C-reactive protein: is the available information reliable?
    Braga F; Panteghini M
    Clin Chim Acta; 2012 Aug; 413(15-16):1179-83. PubMed ID: 22525742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an improved immunoturbidimetic assay for serum C-reactive protein on a COBAS INTEGRA 400 Analyzer.
    Sánchez A; Mirabel JL; Barrenechea E; Eugui J; Puelles A; Castañeda A
    Clin Lab; 2002; 48(5-6):313-7. PubMed ID: 12071582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive determination of C-reactive protein on the Innotrac Aio! immunoanalyzer.
    Hedberg P; Ylitalo K; Puukka M
    Scand J Clin Lab Invest; 2004; 64(7):677-85. PubMed ID: 15513325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: a new risk assessment tool for cardiovascular disease.
    Clearfield MB
    J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 3 automated assays for C-reactive protein in end-stage renal disease: clinical and epidemiological implications.
    Maggiore U; Cristol JP; Canaud B; Dupuy AM; Formica M; Pozzato M; Panichi V; Consani C; Metelli MR; Sereni L; De Nitti C; David S; Tetta C
    J Lab Clin Med; 2005 Jun; 145(6):305-8. PubMed ID: 15976758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.
    Kathiresan S; Larson MG; Vasan RS; Guo CY; Gona P; Keaney JF; Wilson PW; Newton-Cheh C; Musone SL; Camargo AL; Drake JA; Levy D; O'Donnell CJ; Hirschhorn JN; Benjamin EJ
    Circulation; 2006 Mar; 113(11):1415-23. PubMed ID: 16534007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study.
    Bos MJ; Schipper CM; Koudstaal PJ; Witteman JC; Hofman A; Breteler MM
    Circulation; 2006 Oct; 114(15):1591-8. PubMed ID: 17015791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of C-reactive protein with an ultra-sensitivity immunochemiluminometric assay.
    Shiesh SC; Chou TC; Lin XZ; Kao PC
    J Immunol Methods; 2006 Apr; 311(1-2):87-95. PubMed ID: 16546205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum C-reactive protein as a marker for wellness assessment.
    Kao PC; Shiesh SC; Wu TJ
    Ann Clin Lab Sci; 2006; 36(2):163-9. PubMed ID: 16682512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations?
    Sattar N; Lowe GD
    Ann Clin Biochem; 2006 Jul; 43(Pt 4):252-6. PubMed ID: 16824274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
    Janković B; Pasić S; Marković M; Veljković D; Milicić M
    Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.